O-GlcNAcylation Modification in Immune Cells: Potential Therapeutic Implications of Sepsis

O-GlcNAc modification is a glycosylation modification that is commonly observed in nuclear and organelle proteins of cells. In recent years, several studies have shown that O-GlcNAc modification plays an important regulatory role in immune cells, which regulates their activity and function and inhib...

Full description

Saved in:
Bibliographic Details
Published inIntensive care research Vol. 3; no. 3; pp. 204 - 214
Main Authors Huang, ZhenZhen, Qin, YuanMei
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.09.2023
Springer
Subjects
Immune cells
Inflammation
Medicine
Medicine & Public Health
O-GlcNAcylation modification
Review Article
Sepsis
Sepsis
Inflammation
Immune cells
O-GlcNAcylation modification
Online AccessGet full text

Cover

Abstract O-GlcNAc modification is a glycosylation modification that is commonly observed in nuclear and organelle proteins of cells. In recent years, several studies have shown that O-GlcNAc modification plays an important regulatory role in immune cells, which regulates their activity and function and inhibits inflammatory responses. It also enhances immune cells recognition and clearance of pathogens, and improves the host´s antibacterial immune response. Sepsis is a systemic inflammatory response to infection, whose development and progression are regulated by the immune system. Therefore, in the present review, we will discuss the mechanism of O-GlcNAc modification in immune cells and its potential therapeutic value in sepsis, which will be expected to provide new insights and targets for the treatment of sepsis.
AbstractList O-GlcNAc modification is a glycosylation modification that is commonly observed in nuclear and organelle proteins of cells. In recent years, several studies have shown that O-GlcNAc modification plays an important regulatory role in immune cells, which regulates their activity and function and inhibits inflammatory responses. It also enhances immune cells recognition and clearance of pathogens, and improves the host´s antibacterial immune response. Sepsis is a systemic inflammatory response to infection, whose development and progression are regulated by the immune system. Therefore, in the present review, we will discuss the mechanism of O-GlcNAc modification in immune cells and its potential therapeutic value in sepsis, which will be expected to provide new insights and targets for the treatment of sepsis.
Abstract O-GlcNAc modification is a glycosylation modification that is commonly observed in nuclear and organelle proteins of cells. In recent years, several studies have shown that O-GlcNAc modification plays an important regulatory role in immune cells, which regulates their activity and function and inhibits inflammatory responses. It also enhances immune cells recognition and clearance of pathogens, and improves the host´s antibacterial immune response. Sepsis is a systemic inflammatory response to infection, whose development and progression are regulated by the immune system. Therefore, in the present review, we will discuss the mechanism of O-GlcNAc modification in immune cells and its potential therapeutic value in sepsis, which will be expected to provide new insights and targets for the treatment of sepsis.
Author Huang, ZhenZhen
Qin, YuanMei
Author_xml – sequence: 1
  givenname: ZhenZhen
  surname: Huang
  fullname: Huang, ZhenZhen
  organization: Department of Emergency Medicine, Zhoukou Central Hospital
– sequence: 2
  givenname: YuanMei
  surname: Qin
  fullname: Qin, YuanMei
  email: Qinyuanmei69@163.com
  organization: Henan University of Chinese Medicine
BookMark eNp9kMtOwkAUhicGExF5AVd9gerc2um4I0SRBMVE3LiZzOUUh5QOmYEFb2-lxLhydS75_y_n_Ndo0IYWELol-I5gLO4T55SRHFOWY4x5lZMLNKRlWeayKungT3-FxiltOhGtBJW4GKLPZT5r7OvEHhu996HNXoLztbf94Ntsvt0eWsim0DTpIXsLe2j3XjfZ6gui3sFh722n2TVnS8pCnb3DLvl0gy5r3SQYn-sIfTw9rqbP-WI5m08ni9wSKUguMCcOuCHMGF1YkLYoXV1XEjtdMi0tmNparnnhSiOFKYyTteSuwCBsUTk2QvOe64LeqF30Wx2PKmivTosQ10rH7swGFJG0BMaJEFZzXgijwTKBKcdCMsNsx6I9y8aQUoT6l0ew-glb9WGrLmx1CluRzsR6U-rE7Rqi2oRDbLuf_3N9AzgLhGE
Cites_doi 10.1177/0271678X16679671
10.1111/bph.12223
10.1038/nrm.2017.22
10.4037/ajcc2016432
10.3390/metabo12080725
10.3390/ijms22179236
10.3390/cells10112962
10.1016/j.biopha.2021.111477
10.3389/fcimb.2017.00373
10.3390/ijms21072356
10.1074/jbcM116.766568
10.1111/mmi.13849
10.1074/jbc.M116.737940
10.1128/MMBR.00027-07
10.4049/jimmunol.0903151
10.1097/WNR.0000000000001582
10.1016/j.clim.2004.08.015
10.1186/s13073-019-0674-2
10.3389/fphys.2019.01614
10.3389/fimmu.2016.00155
10.1016/j.cell.2016.05.056
10.1146/annurev-physiol-061121-040214
10.1021/acschembio.7b00869
10.1097/CCM.0000000000002380
10.1016/j.ejphar.2020.173090
10.1038/s41388-018-0435-5
10.1038/s41598-019-55381-7
10.1371/journal.ppat.1004701
10.1016/j.intimp.2021.107791
10.2174/1389203720666190305164128
10.2174/1871529x15666150108113236
10.3389/fimmu.2022.841299
10.1038/sj.emboj.7601845
10.1128/JB.00234-06
10.1038/ncomms12526
10.1016/j.immuni.2019.01.007
10.1073/pnas.1521740112
10.4049/jimmunol.181.8.5481
10.1371/journal.ppat.1003080
10.4049/jimmunol.175.12.8003
10.3389/fendo.2022.943576
10.1016/j.bbagen.2013.09.011
10.1038/s41568-018-0090-8
10.1111/imm.12854
10.1016/S0021-9258(17)43295-9
10.1016/j.jaci.2013.01.046
10.3390/cancers13071666
10.3390/ijms231911260
10.1146/annurev.Immunol.021908.132706
10.1073/pnas.1214550110
10.1073/pnas.1801850115
10.1007/s12017-019-08584-0
10.1001/jama.2016.0287
10.1002/cyto.a.20569
10.4049/jimmunol.1302259
10.1097/01.shk.0000068322.08268.b4
10.1038/ni.3439
10.1038/nm0509-496
10.4161/viru.26516
10.1038/s41590-020-0789-z
10.1074/jbc.RA119.008373
10.1007/s00011-016-0970-x
10.1111/cmi.12304
10.1111/febs.14491
10.1084/jem.20161105
10.1074/jbc.RA118.004638
10.3390/ijms23126430
10.1073/pnas.1323226111
10.1038/s41467-018-04719-2
10.1073/pnas.2119658120
10.1074/jbc.M414066200
10.1038/sj.cr.7290215
10.3389/fimmu.2021.701675
10.1152/physrev.00043.2019
10.1038/s41467-019-08300-3
10.1016/s1074-7613(02)00333-3
10.1038/s41467-017-01677-z
10.1007/s10863-017-9735-7
10.4049/jimmunol.1601727
10.1177/154411130201300302
10.1007/s10863-018-9744-1
10.1152/ajpcell.00042.2013
10.1128/JB.01175-10
10.1126/scisignal.20040
10.1074/jbc.M407911200
10.1073/pnas.0405821101
10.1016/j.redox.2022.102581
ContentType Journal Article
Copyright The Author(s) 2023
Copyright_xml – notice: The Author(s) 2023
DBID C6C
AAYXX
CITATION
DOA
DOI 10.1007/s44231-023-00048-1
DatabaseName SpringerOpen
CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList

CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2666-9862
EndPage 214
ExternalDocumentID oai_doaj_org_article_1926e34177ca4457baec370240793b3c
10_1007_s44231_023_00048_1
GroupedDBID 0R~
AAKKN
AAYZJ
ABDBF
ABEEZ
ACACY
ACULB
AFGXO
ALMA_UNASSIGNED_HOLDINGS
C24
C6C
EBS
GROUPED_DOAJ
M~E
RSV
SOJ
AAYXX
CITATION
ID FETCH-LOGICAL-c1971-7041de4b13bba5ce9c56dff890da63a9cebfcc4a45d6b97b5bd9f94d50e7c58d3
IEDL.DBID DOA
ISSN 2666-9862
IngestDate Wed Aug 27 01:30:42 EDT 2025
Tue Jul 01 03:24:41 EDT 2025
Fri Feb 21 02:43:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Sepsis
Inflammation
Immune cells
O-GlcNAcylation modification
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1971-7041de4b13bba5ce9c56dff890da63a9cebfcc4a45d6b97b5bd9f94d50e7c58d3
OpenAccessLink https://doaj.org/article/1926e34177ca4457baec370240793b3c
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_1926e34177ca4457baec370240793b3c
crossref_primary_10_1007_s44231_023_00048_1
springer_journals_10_1007_s44231_023_00048_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230900
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 9
  year: 2023
  text: 20230900
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
PublicationTitle Intensive care research
PublicationTitleAbbrev Intensive Care Res
PublicationYear 2023
Publisher Springer Netherlands
Springer
Publisher_xml – name: Springer Netherlands
– name: Springer
References Kneass, Marchase (CR59) 2004
Lorente-Sorolla, Garcia-Gomez, Català-Moll (CR6) 2019
von Knethen, Heinicke, Weigert (CR20) 2020
Hwang, Kim, Park (CR55) 2019
Vatanen, Kostic (CR73) 2016
Chatham, Zhang, Wende (CR24) 2021
Lo, Shie, Chen (CR68) 2018
Yao, Tang, Wang (CR63) 2004
Boamah, Gilmore, Bourget (CR83) 2023
Singer, Deutschman, Seymour (CR1) 2016
Wesselkamper, Eppert, Motz (CR72) 2008
Torres, Hart (CR21) 1984; 259
Golks, Tran, Goetschy (CR32) 2007
Nedeva, Menassa, Duan (CR11) 2020
Cicchetti, Allen, Glogauer (CR62) 2002
Feinberg, Ramakrishnan, Wong (CR70) 2022
Chen, Liu, Gao (CR54) 2021
Li, Zhang, Li (CR52) 2017
Silva-Aguiar, Peruchetti, Pinheiro (CR7) 2022
Hwang, Kwon, Kim (CR49) 2017
Liu, Dong, Li (CR27) 2022
Johnson, Opimba, Bernier (CR35) 2014
Chu, Lo, Yeh (CR67) 2014
Lerman, Kim (CR56) 2015
Kneass, Marchase (CR61) 2005
Shah, Zúñiga-Pflücker (CR30) 2014
Liu, Ma, Chen (CR36) 2017
Cao, Schnelzer, Hannemann (CR4) 2021
van der Laarse, Leney, Heck (CR31) 2018
Yang, Qian (CR25) 2017
Lockridge, Hanover (CR22) 2022
Wheeler, Chevalier, Eberl (CR82) 2014
He, Ma, Li, Thiamet (CR48) 2017
Wang, Lu, Zheng (CR77) 2021
Vatanen, Kostic (CR13) 2016; 4
Bhan, Dipankar, Chakraborty (CR19) 2016
Nguyen, Green, Mecsas (CR12) 2017
Ma, Chalkley, Vosseller (CR33) 2017
Swamy, Pathak, Grzes (CR29) 2016
Pieper, Grimbacher, Eibel (CR42) 2013
Yunna, Mengru, Lei (CR53) 2020
Pachot, Monneret, Voirin (CR18) 2005
Hotchkiss, Coopersmith, McDunn (CR3) 2009
Ferron, Cadiet, Persello (CR8) 2019
Parker, Peterson, Slawson (CR26) 2021
Hwang, Hwang, Kim (CR46) 2013
Dupas, Persello, Blangy-Letheule (CR79) 2022
Wu, Su, Zha (CR78) 2023
Guo, Patil, Luan (CR71) 2018
Denis, Dupas, Persello (CR76) 2021
Sohanpal, El-Labany, Lahooti (CR88) 2004
Wu, Wu, Tsai (CR44) 2016
Sônego, Castanheira, Ferreira (CR57) 2016
Jamieson, Diefenbach, McMahon (CR64) 2002
Silva, Olivon, Mestriner (CR75) 2019
Qiu, Tu, Ju (CR9) 2019
Wu, Chiang, Hsu (CR43) 2017
Korgaonkar, Whiteley (CR80) 2011
Wiesner, Specht, Lee (CR86) 2015
Torres, Pickkers, van der Poll (CR2) 2022
Janas, Groves, Kienzle (CR40) 2005
Madsen-Bouterse, Xu, Petty (CR58) 2008
Barnhart, Lynem, Chapman (CR89) 2006
Shankar-Hari, Fear, Lavender (CR45) 2017
Jiang, Xu, Li (CR65) 2019
Bueter, Specht, Levitz (CR85) 2013
Unsinger, McGlynn, Kasten (CR15) 2010
Ferron, Cadiet, Persello (CR74) 2019
Sharma, Saluja, Banerjee (CR23) 2018
Hwang, Hwang, Kim (CR47) 2013
Korgaonkar, Trivedi, Rumbaugh (CR87) 2013
Ramakrishnan, Clark, Mason (CR34) 2013
Smith-Garvin, Koretzky, Jordan (CR39) 2009
Liu, Salgado, Singh (CR38) 2019
Lopez Aguilar, Gao, Hou (CR41) 2017
Boomer, Green, Hotchkiss (CR10) 2014
Park, Lai, Arumugam (CR28) 2020
Yin, Leavenworth, Li (CR66) 2015
Hynninen, Pettilä, Takkunen (CR14) 2003
Machacek, Slawson, Fields (CR16) 2018
Machacek, Saunders, Zhang (CR37) 2019
Loftus, Assmann, Kedia-Mehta (CR69) 2018
Greathouse, Hall (CR17) 2016
Huynh, Chand, Gough (CR51) 2019
Li, Gong, Wang (CR50) 2019
Santarsiero, Convertini, Todisco (CR5) 2021
Cong, Sun, Yang (CR60) 2021
Park, Uehara (CR81) 2008
Bonnet, Durmort, Jacq (CR84) 2017
C Liu (48_CR27) 2022
JL Wu (48_CR44) 2016
Y Guo (48_CR71) 2018
A Pachot (48_CR18) 2005
SA Madsen-Bouterse (48_CR58) 2008
CL Bueter (48_CR85) 2013
MP Parker (48_CR26) 2021
B Liu (48_CR38) 2019
A Santarsiero (48_CR5) 2021
A Korgaonkar (48_CR87) 2013
JT Park (48_CR81) 2008
C Nedeva (48_CR11) 2020
F Sônego (48_CR57) 2016
A Lopez Aguilar (48_CR41) 2017
K Pieper (48_CR42) 2013
JC Chatham (48_CR24) 2021
J Unsinger (48_CR15) 2010
J Wang (48_CR77) 2021
D Wu (48_CR78) 2023
RP Silva-Aguiar (48_CR7) 2022
GT Nguyen (48_CR12) 2017
R Liu (48_CR36) 2017
R Wheeler (48_CR82) 2014
M Swamy (48_CR29) 2016
S van der Laarse (48_CR31) 2018
AK Korgaonkar (48_CR80) 2011
J Huynh (48_CR51) 2019
Y Qiu (48_CR9) 2019
JF Silva (48_CR75) 2019
SC Wesselkamper (48_CR72) 2008
A Golks (48_CR32) 2007
X Yang (48_CR25) 2017
JS Boomer (48_CR10) 2014
M Denis (48_CR76) 2021
BK Sohanpal (48_CR88) 2004
M Machacek (48_CR16) 2018
DK Shah (48_CR30) 2014
ZT Kneass (48_CR61) 2005
ML Janas (48_CR40) 2005
ZT Kneass (48_CR59) 2004
T Dupas (48_CR79) 2022
J Yin (48_CR66) 2015
PW Lo (48_CR68) 2018
SY Hwang (48_CR46) 2013
AM Jamieson (48_CR64) 2002
CR Torres (48_CR21) 1984; 259
RS Hotchkiss (48_CR3) 2009
M Ferron (48_CR74) 2019
JS Hwang (48_CR55) 2019
G Cicchetti (48_CR62) 2002
M Singer (48_CR1) 2016
JS Hwang (48_CR49) 2017
R Cong (48_CR60) 2021
X Li (48_CR52) 2017
LK Torres (48_CR2) 2022
J Bonnet (48_CR84) 2017
M Shankar-Hari (48_CR45) 2017
T Vatanen (48_CR73) 2016
JL Wu (48_CR43) 2017
DL Wiesner (48_CR86) 2015
T Vatanen (48_CR13) 2016; 4
A von Knethen (48_CR20) 2020
B Johnson (48_CR35) 2014
M Ferron (48_CR8) 2019
NS Sharma (48_CR23) 2018
MM Barnhart (48_CR89) 2006
X Chen (48_CR54) 2021
AY Yao (48_CR63) 2004
CS Chu (48_CR67) 2014
A Lockridge (48_CR22) 2022
C Lorente-Sorolla (48_CR6) 2019
C Bhan (48_CR19) 2016
M Hynninen (48_CR14) 2003
X Li (48_CR50) 2019
S Cao (48_CR4) 2021
M Machacek (48_CR37) 2019
RM Loftus (48_CR69) 2018
JE Smith-Garvin (48_CR39) 2009
D Feinberg (48_CR70) 2022
J Park (48_CR28) 2020
M Jiang (48_CR65) 2019
Z Ma (48_CR33) 2017
P Ramakrishnan (48_CR34) 2013
SY Hwang (48_CR47) 2013
Y He (48_CR48) 2017
C Yunna (48_CR53) 2020
D Boamah (48_CR83) 2023
KC Greathouse (48_CR17) 2016
YV Lerman (48_CR56) 2015
References_xml – year: 2017
  ident: CR48
  article-title: Mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1177/0271678X16679671
– year: 2013
  ident: CR47
  article-title: O-GlcNAcylation and p50/p105 binding of c-Rel are dynamically regulated by LPS and glucosamine in BV2 microglia cells
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.12223
– year: 2017
  ident: CR25
  article-title: Protein O-GlcNAcylation: emerging mechanisms and functions
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm.2017.22
– year: 2016
  ident: CR17
  article-title: Critical Illness-induced immune suppression: current state of the science
  publication-title: Am J Crit Care
  doi: 10.4037/ajcc2016432
– year: 2022
  ident: CR27
  article-title: O-GlcNAc modification and its role in diabetic retinopathy
  publication-title: Metabolites
  doi: 10.3390/metabo12080725
– year: 2021
  ident: CR76
  article-title: An -GlcNAcylomic approach reveals ACLY as a potential target in sepsis in the young rat
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22179236
– year: 2021
  ident: CR5
  article-title: ACLY nuclear translocation in human macrophages drives proinflammatory gene expression by NF-κB acetylation
  publication-title: Cells
  doi: 10.3390/cells10112962
– year: 2021
  ident: CR60
  article-title: Protein O-GlcNAcylation alleviates small intestinal injury induced by ischemia-reperfusion and oxygen-glucose deprivation
  publication-title: Biomed Pharmacother.
  doi: 10.1016/j.biopha.2021.111477
– year: 2017
  ident: CR12
  article-title: Neutrophils to the ROScue: mechanisms of NADPH oxidase activation and bacterial resistance
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2017.00373
– year: 2020
  ident: CR20
  article-title: Histone deacetylation inhibitors as modulators of regulatory T cells
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21072356
– year: 2017
  ident: CR33
  article-title: Hyper- -GlcNAcylation activates nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling through interplay with phosphorylation and acetylation
  publication-title: J Biol Chem
  doi: 10.1074/jbcM116.766568
– year: 2017
  ident: CR84
  article-title: Peptidoglycan -acetylation is functionally related to cell wall biosynthesis and cell division in Streptococcus pneumoniae
  publication-title: Mol Microbiol
  doi: 10.1111/mmi.13849
– year: 2017
  ident: CR49
  article-title: Lipopolysaccharide (LPS)-stimulated iNOS induction is increased by glucosamine under normal glucose conditions but is inhibited by glucosamine under high glucose conditions in macrophage cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M116.737940
– year: 2008
  ident: CR81
  article-title: How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan)
  publication-title: Microbiol Mol Biol Rev
  doi: 10.1128/MMBR.00027-07
– year: 2010
  ident: CR15
  article-title: IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0903151
– year: 2021
  ident: CR77
  article-title: Glutamine's protection against brain damage in septic rats via increased protein oxygen- -acetylglucosamine modification
  publication-title: NeuroReport
  doi: 10.1097/WNR.0000000000001582
– year: 2005
  ident: CR18
  article-title: Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2004.08.015
– year: 2019
  ident: CR6
  article-title: Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis
  publication-title: Genome Med
  doi: 10.1186/s13073-019-0674-2
– year: 2019
  ident: CR75
  article-title: Acute increase in -GlcNAc improves survival in mice with LPS-induced systemic inflammatory response syndrome
  publication-title: Front Physiol
  doi: 10.3389/fphys.2019.01614
– year: 2016
  ident: CR57
  article-title: Paradoxical roles of the neutrophil in sepsis: protective and deleterious
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2016.00155
– year: 2016
  ident: CR73
  article-title: Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans
  publication-title: Cell.
  doi: 10.1016/j.cell.2016.05.056
– year: 2022
  ident: CR2
  article-title: Sepsis-Induced Immunosuppression
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev-physiol-061121-040214
– year: 2017
  ident: CR41
  article-title: Profiling of protein -GlcNAcylation in murine CD8(+) effector− and memory-like T cells
  publication-title: ACS Chem Biol
  doi: 10.1021/acschembio.7b00869
– year: 2017
  ident: CR45
  article-title: Activation—associated accelerated apoptosis of memory B cells in critically ill patients with sepsis
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000002380
– year: 2020
  ident: CR53
  article-title: Macrophage M1/M2 polarization
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2020.173090
– year: 2019
  ident: CR65
  article-title: O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0435-5
– year: 2019
  ident: CR8
  article-title: O-GlcNAc stimulation: a new metabolic approach to treat septic shock
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-55381-7
– year: 2015
  ident: CR86
  article-title: Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004701
– year: 2021
  ident: CR54
  article-title: The roles of macrophage polarization in the host immune response to sepsis
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.107791
– year: 2019
  ident: CR9
  article-title: The immune system regulation in sepsis: from innate to adaptive
  publication-title: Curr Protein Pept Sci
  doi: 10.2174/1389203720666190305164128
– year: 2015
  ident: CR56
  article-title: Neutrophil migration under normal and sepsis conditions
  publication-title: Cardiovasc Hematol Disord Drug Targets
  doi: 10.2174/1871529x15666150108113236
– year: 2022
  ident: CR70
  article-title: Inhibition of -GlcNAcylation decreases the cytotoxic function of natural killer cells
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.841299
– year: 2007
  ident: CR32
  article-title: Requirement for -linked -acetylglucosaminyltransferase in lymphocytes activation
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601845
– year: 2006
  ident: CR89
  article-title: GlcNAc-6P levels modulate the expression of Curli fibers by
  publication-title: J Bacteriol
  doi: 10.1128/JB.00234-06
– year: 2016
  ident: CR44
  article-title: Temporal regulation of Lsp1 -GlcNAcylation and phosphorylation during apoptosis of activated B cells
  publication-title: Nat Commun
  doi: 10.1038/ncomms12526
– year: 2019
  ident: CR50
  article-title: O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting serine/threonine-protein kinase 3
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.01.007
– year: 2015
  ident: CR66
  article-title: Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
  publication-title: Proc Natl Acad Sci US A
  doi: 10.1073/pnas.1521740112
– year: 2008
  ident: CR72
  article-title: NKG2D is critical for NK cell activation in host defense against pseudomonas aeruginosa respiratory infection
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.8.5481
– year: 2013
  ident: CR85
  article-title: Innate sensing of chitin and chitosan
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003080
– year: 2005
  ident: CR40
  article-title: IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.175.12.8003
– year: 2022
  ident: CR22
  article-title: A nexus of lipid and O-Glcnac metabolism in physiology and disease
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2022.943576
– year: 2014
  ident: CR35
  article-title: Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2013.09.011
– year: 2019
  ident: CR51
  article-title: Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0090-8
– year: 2018
  ident: CR71
  article-title: The biology of natural killer cells during sepsis
  publication-title: Immunology
  doi: 10.1111/imm.12854
– volume: 259
  start-page: 3308
  issue: 5
  year: 1984
  end-page: 17
  ident: CR21
  article-title: Topography and polypeptide distribution of terminal -acetylglucosamine residues on the surfaces of intact lymphocytes evidence for O-linked GlcNAc
  publication-title: J Biol Chem.
  doi: 10.1016/S0021-9258(17)43295-9
– year: 2013
  ident: CR42
  article-title: B-cell biology and development
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.01.046
– year: 2021
  ident: CR26
  article-title: O-GlcNAcylation and O-GlcNAc cycling regulate gene transcription: emerging roles in cancer
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13071666
– year: 2022
  ident: CR7
  article-title: O-GlcNAcylation in renal (Patho)physiology
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms231911260
– year: 2009
  ident: CR39
  article-title: T cell activation
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.Immunol.021908.132706
– year: 2013
  ident: CR87
  article-title: Community surveillance enhances virulence during polymicrobial infection
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1214550110
– year: 2018
  ident: CR68
  article-title: -GlcNAcylation regulates the stability and enzymatic activity of the histone methyltransferase EZH2
  publication-title: Natl Acad Sci USA
  doi: 10.1073/pnas.1801850115
– year: 2020
  ident: CR28
  article-title: O-GlcNAcylation as a therapeutic target for Alzheimer’s disease
  publication-title: Neuromo-lecular Med
  doi: 10.1007/s12017-019-08584-0
– year: 2019
  ident: CR74
  article-title: O-GlcNAc stimulation: a new metabolic approach to treat septic shock
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-55381-7
– year: 2016
  ident: CR1
  article-title: The third international consensus definitions for sepsis and septic shock (Sepsis-3)
  publication-title: JAMA
  doi: 10.1001/jama.2016.0287
– year: 2008
  ident: CR58
  article-title: Quantification of -GlcNAc protein modification in neutrophils by flow cytometry
  publication-title: Cytometry A
  doi: 10.1002/cyto.a.20569
– year: 2014
  ident: CR30
  article-title: An overview of the intrathymic intricacies of T cell development
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1302259
– year: 2003
  ident: CR14
  article-title: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis[J]
  publication-title: Shock
  doi: 10.1097/01.shk.0000068322.08268.b4
– year: 2016
  ident: CR29
  article-title: Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy
  publication-title: Nat Immunol
  doi: 10.1038/ni.3439
– year: 2009
  ident: CR3
  article-title: The sepsis seesaw: tilting toward immunosuppression
  publication-title: Nat Med
  doi: 10.1038/nm0509-496
– year: 2014
  ident: CR10
  article-title: The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
  publication-title: Virulence
  doi: 10.4161/viru.26516
– year: 2020
  ident: CR11
  article-title: TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0789-z
– year: 2019
  ident: CR37
  article-title: Elevated -GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA119.008373
– year: 2016
  ident: CR19
  article-title: Role of cellular events in the pathophysiology of sepsis
  publication-title: Inflamm Res
  doi: 10.1007/s00011-016-0970-x
– year: 2014
  ident: CR82
  article-title: The biology of bacterial peptidoglycans and their impact on host immunity and physiology
  publication-title: Cell Microbiol
  doi: 10.1111/cmi.12304
– year: 2018
  ident: CR31
  article-title: Crosstalk between phosphorylation and O-GlcNAcylation: friend or foe
  publication-title: FEBS J
  doi: 10.1111/febs.14491
– year: 2017
  ident: CR52
  article-title: Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation
  publication-title: J Exp Med
  doi: 10.1084/jem.20161105
– year: 2019
  ident: CR55
  article-title: Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA118.004638
– year: 2022
  ident: CR79
  article-title: Beneficial effects of O-GlcNAc stimulation in a young rat model of sepsis: beyond modulation of gene expression
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23126430
– year: 2014
  ident: CR67
  article-title: O-GlcNAcylation regulates EZH2 protein stability and function
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1323226111
– year: 2018
  ident: CR69
  article-title: Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-04719-2
– year: 2023
  ident: CR83
  article-title: Peptidoglycan deacetylation controls type IV secretion and the intracellular survival of the bacterial pathogen Legionella pneumophila
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2119658120
– volume: 4
  start-page: 07
  year: 2016
  ident: CR13
  article-title: Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans
  publication-title: Cell.
– year: 2005
  ident: CR61
  article-title: Protein -GlcNAc modulates motility-associated signaling intermediates in neutrophils
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M414066200
– year: 2004
  ident: CR63
  article-title: Inhibition of the activating signals in NK92 cells by recombinant GST-sHLA-G1a chain
  publication-title: Cell Res
  doi: 10.1038/sj.cr.7290215
– year: 2021
  ident: CR4
  article-title: The transcription factor FRA-1/AP-1 controls lipocalin-2 expression and inflammation in sepsis model
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.701675
– year: 2021
  ident: CR24
  article-title: Role of O-linked -acetylglucosamine protein modification in cellular (patho)physiology
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00043.2019
– year: 2019
  ident: CR38
  article-title: The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-08300-3
– year: 2002
  ident: CR64
  article-title: The role of the NKG2D immunoreceptor in immune cell activation and natural killing
  publication-title: Immunity
  doi: 10.1016/s1074-7613(02)00333-3
– year: 2017
  ident: CR43
  article-title: -GlcNAcylation is required for B cell homeostasis and antibody responses
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01677-z
– year: 2018
  ident: CR23
  article-title: Nutrient-sensing and self-renewal: O-GlcNAc in a new role
  publication-title: J Bioenerg Biomembr
  doi: 10.1007/s10863-017-9735-7
– year: 2017
  ident: CR36
  article-title: MicroRNA-15b suppresses 17th differentiation and is associated with pathogenesis of multiple sclerosis by targeting O-GlcNAc transferase
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1601727
– year: 2002
  ident: CR62
  article-title: Chemotactic signaling pathways in neutrophils: from receptor to actin assembly
  publication-title: Crit Rev Oral Biol Med
  doi: 10.1177/154411130201300302
– year: 2018
  ident: CR16
  article-title: O-GlcNAc: a novel regulator of immunometabolism
  publication-title: J Bioenerg Biomembr
  doi: 10.1007/s10863-018-9744-1
– year: 2013
  ident: CR46
  article-title: O-GlcNAc transferase inhibitsLPS-mediated expression of inducible nitric oxide synthase through an increased interaction with mSin3A in RAW264.7 cells
  publication-title: Am J Physiol Cell Physiol.
  doi: 10.1152/ajpcell.00042.2013
– year: 2011
  ident: CR80
  article-title: Pseudomonas aeruginosa enhances production of an antimicrobial in response to -acetylglucosamine and peptidoglycan
  publication-title: J Bacteriol
  doi: 10.1128/JB.01175-10
– year: 2013
  ident: CR34
  article-title: Activation of the transcriptional function of the NF-κB protein c-Rel by -GlcNAc glycosylation
  publication-title: Sci Signal.
  doi: 10.1126/scisignal.20040
– year: 2004
  ident: CR59
  article-title: Neutrophils exhibit rapid agonist-induced increases in protein-associated -GlcNAc
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M407911200
– year: 2004
  ident: CR88
  article-title: Integrated regulatory responses of fimB to -acetylneuraminic (sialic) acid and GlcNAc in K-12
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0405821101
– year: 2023
  ident: CR78
  article-title: Glutamine promotes O-GlcNAcylation of G6PD and inhibits AGR2 -glutathionylation to maintain the intestinal mucus barrier in burned septic mice
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2022.102581
– year: 2019
  ident: 48_CR8
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-55381-7
– year: 2023
  ident: 48_CR83
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2119658120
– year: 2009
  ident: 48_CR3
  publication-title: Nat Med
  doi: 10.1038/nm0509-496
– year: 2020
  ident: 48_CR11
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0789-z
– year: 2016
  ident: 48_CR29
  publication-title: Nat Immunol
  doi: 10.1038/ni.3439
– year: 2018
  ident: 48_CR31
  publication-title: FEBS J
  doi: 10.1111/febs.14491
– year: 2016
  ident: 48_CR17
  publication-title: Am J Crit Care
  doi: 10.4037/ajcc2016432
– year: 2020
  ident: 48_CR53
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2020.173090
– year: 2017
  ident: 48_CR48
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1177/0271678X16679671
– year: 2021
  ident: 48_CR24
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00043.2019
– year: 2017
  ident: 48_CR36
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1601727
– year: 2018
  ident: 48_CR69
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-04719-2
– year: 2003
  ident: 48_CR14
  publication-title: Shock
  doi: 10.1097/01.shk.0000068322.08268.b4
– year: 2017
  ident: 48_CR41
  publication-title: ACS Chem Biol
  doi: 10.1021/acschembio.7b00869
– year: 2004
  ident: 48_CR88
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0405821101
– year: 2021
  ident: 48_CR54
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.107791
– year: 2019
  ident: 48_CR37
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA119.008373
– year: 2006
  ident: 48_CR89
  publication-title: J Bacteriol
  doi: 10.1128/JB.00234-06
– year: 2007
  ident: 48_CR32
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601845
– year: 2013
  ident: 48_CR85
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003080
– year: 2016
  ident: 48_CR44
  publication-title: Nat Commun
  doi: 10.1038/ncomms12526
– year: 2022
  ident: 48_CR70
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.841299
– year: 2019
  ident: 48_CR74
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-55381-7
– year: 2019
  ident: 48_CR75
  publication-title: Front Physiol
  doi: 10.3389/fphys.2019.01614
– year: 2013
  ident: 48_CR42
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.01.046
– year: 2016
  ident: 48_CR57
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2016.00155
– year: 2002
  ident: 48_CR62
  publication-title: Crit Rev Oral Biol Med
  doi: 10.1177/154411130201300302
– year: 2015
  ident: 48_CR66
  publication-title: Proc Natl Acad Sci US A
  doi: 10.1073/pnas.1521740112
– year: 2016
  ident: 48_CR1
  publication-title: JAMA
  doi: 10.1001/jama.2016.0287
– year: 2019
  ident: 48_CR51
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0090-8
– year: 2019
  ident: 48_CR50
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.01.007
– volume: 4
  start-page: 07
  year: 2016
  ident: 48_CR13
  publication-title: Cell.
– year: 2018
  ident: 48_CR16
  publication-title: J Bioenerg Biomembr
  doi: 10.1007/s10863-018-9744-1
– year: 2008
  ident: 48_CR58
  publication-title: Cytometry A
  doi: 10.1002/cyto.a.20569
– year: 2022
  ident: 48_CR2
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev-physiol-061121-040214
– year: 2008
  ident: 48_CR72
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.8.5481
– year: 2017
  ident: 48_CR33
  publication-title: J Biol Chem
  doi: 10.1074/jbcM116.766568
– year: 2014
  ident: 48_CR30
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1302259
– year: 2022
  ident: 48_CR79
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23126430
– year: 2013
  ident: 48_CR34
  publication-title: Sci Signal.
  doi: 10.1126/scisignal.20040
– year: 2002
  ident: 48_CR64
  publication-title: Immunity
  doi: 10.1016/s1074-7613(02)00333-3
– year: 2021
  ident: 48_CR4
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.701675
– year: 2022
  ident: 48_CR22
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2022.943576
– year: 2017
  ident: 48_CR25
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm.2017.22
– year: 2005
  ident: 48_CR61
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M414066200
– year: 2019
  ident: 48_CR65
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0435-5
– year: 2022
  ident: 48_CR27
  publication-title: Metabolites
  doi: 10.3390/metabo12080725
– year: 2017
  ident: 48_CR12
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2017.00373
– year: 2020
  ident: 48_CR28
  publication-title: Neuromo-lecular Med
  doi: 10.1007/s12017-019-08584-0
– year: 2013
  ident: 48_CR47
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.12223
– year: 2015
  ident: 48_CR56
  publication-title: Cardiovasc Hematol Disord Drug Targets
  doi: 10.2174/1871529x15666150108113236
– year: 2017
  ident: 48_CR45
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000002380
– year: 2022
  ident: 48_CR7
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms231911260
– year: 2019
  ident: 48_CR38
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-08300-3
– year: 2014
  ident: 48_CR10
  publication-title: Virulence
  doi: 10.4161/viru.26516
– year: 2021
  ident: 48_CR77
  publication-title: NeuroReport
  doi: 10.1097/WNR.0000000000001582
– year: 2021
  ident: 48_CR5
  publication-title: Cells
  doi: 10.3390/cells10112962
– year: 2015
  ident: 48_CR86
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004701
– year: 2013
  ident: 48_CR46
  publication-title: Am J Physiol Cell Physiol.
  doi: 10.1152/ajpcell.00042.2013
– year: 2005
  ident: 48_CR18
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2004.08.015
– year: 2009
  ident: 48_CR39
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.Immunol.021908.132706
– year: 2020
  ident: 48_CR20
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21072356
– year: 2004
  ident: 48_CR59
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M407911200
– volume: 259
  start-page: 3308
  issue: 5
  year: 1984
  ident: 48_CR21
  publication-title: J Biol Chem.
  doi: 10.1016/S0021-9258(17)43295-9
– year: 2021
  ident: 48_CR26
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13071666
– year: 2019
  ident: 48_CR55
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA118.004638
– year: 2019
  ident: 48_CR9
  publication-title: Curr Protein Pept Sci
  doi: 10.2174/1389203720666190305164128
– year: 2017
  ident: 48_CR49
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M116.737940
– year: 2018
  ident: 48_CR71
  publication-title: Immunology
  doi: 10.1111/imm.12854
– year: 2016
  ident: 48_CR73
  publication-title: Cell.
  doi: 10.1016/j.cell.2016.05.056
– year: 2021
  ident: 48_CR76
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22179236
– year: 2010
  ident: 48_CR15
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0903151
– year: 2018
  ident: 48_CR68
  publication-title: Natl Acad Sci USA
  doi: 10.1073/pnas.1801850115
– year: 2019
  ident: 48_CR6
  publication-title: Genome Med
  doi: 10.1186/s13073-019-0674-2
– year: 2014
  ident: 48_CR82
  publication-title: Cell Microbiol
  doi: 10.1111/cmi.12304
– year: 2021
  ident: 48_CR60
  publication-title: Biomed Pharmacother.
  doi: 10.1016/j.biopha.2021.111477
– year: 2017
  ident: 48_CR84
  publication-title: Mol Microbiol
  doi: 10.1111/mmi.13849
– year: 2017
  ident: 48_CR52
  publication-title: J Exp Med
  doi: 10.1084/jem.20161105
– year: 2016
  ident: 48_CR19
  publication-title: Inflamm Res
  doi: 10.1007/s00011-016-0970-x
– year: 2005
  ident: 48_CR40
  publication-title: J Immunol
  doi: 10.4049/jimmunol.175.12.8003
– year: 2014
  ident: 48_CR67
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1323226111
– year: 2018
  ident: 48_CR23
  publication-title: J Bioenerg Biomembr
  doi: 10.1007/s10863-017-9735-7
– year: 2004
  ident: 48_CR63
  publication-title: Cell Res
  doi: 10.1038/sj.cr.7290215
– year: 2011
  ident: 48_CR80
  publication-title: J Bacteriol
  doi: 10.1128/JB.01175-10
– year: 2014
  ident: 48_CR35
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2013.09.011
– year: 2008
  ident: 48_CR81
  publication-title: Microbiol Mol Biol Rev
  doi: 10.1128/MMBR.00027-07
– year: 2013
  ident: 48_CR87
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1214550110
– year: 2023
  ident: 48_CR78
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2022.102581
– year: 2017
  ident: 48_CR43
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01677-z
SSID ssj0002872905
Score 2.2308836
SecondaryResourceType review_article
Snippet O-GlcNAc modification is a glycosylation modification that is commonly observed in nuclear and organelle proteins of cells. In recent years, several studies...
Abstract O-GlcNAc modification is a glycosylation modification that is commonly observed in nuclear and organelle proteins of cells. In recent years, several...
SourceID doaj
crossref
springer
SourceType Open Website
Index Database
Publisher
StartPage 204
SubjectTerms Immune cells
Inflammation
Medicine
Medicine & Public Health
O-GlcNAcylation modification
Review Article
Sepsis
SummonAdditionalLinks – databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEA6iIF7EJ64vcvCmwbR5Nd7WxccKq4IK4qXkMQVh2S52PfjvTdru-kTwUmhJW_gm6cx05vuC0AG48OGXWUFUmhnCE-tJZqkiyjEhmfTUiMhGHlzLywd-9SgeW5mcyIX5Vr8_rnjw9yHhTVnDfyYh01kQCVNxm4ae7M3-p4TIP9VUtLyY32_94ntqif4f9c_arZyvoOU2HsTdxoCraA5Ga2hx0Fa819HTDbkYuuuue2ua1vCg9LG7pzl5HuF-JHgA7sFwWJ3g23IS23_CE-8_iFW4_6ltHJcFvoNx9VxtoIfzs_veJWn3QyAu0SohivLEA7cJs9YIB9oJ6Ysi09QbyYx2YAvnuOHCS6uVFdbrQnMvKCgnMs820fyoHMEWwhpk6kU4CmU40EzLlAJPijTKs3AKHXQ4RSofN7IX-UzguMY1D7jmNa550kGnEczZyChZXV8IlszbFZCHUFJC8JlKOcO5UNaAC2aMGaVmlrkOOpqaIm_XUfXHO7f_N3wHLaX1TIjdYbtofvLyCnshnJjY_XoevQOk4cBa
  priority: 102
  providerName: Springer Nature
Title O-GlcNAcylation Modification in Immune Cells: Potential Therapeutic Implications of Sepsis
URI https://link.springer.com/article/10.1007/s44231-023-00048-1
https://doaj.org/article/1926e34177ca4457baec370240793b3c
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8NAEF60XryIomJ9lD1408VNso-st7ZareADVChewj4mUCltsfXgv3d3E7Ui6MXLQkLIhm8mM7PJN98idAjWB36Rl0SmuSYsMY7khkoibcZFJhzVPHQjX9-Iy0d2NeCDha2-AieskgeugDvxFYgAH2qltJoxLo0Gm8mgzOU9y2Q2RF-f8xYWU8_xk5EvGimvu2RirxzzhYNfOadZ1UhNkm-ZKAr2__gbGpNMbx2t1dUhbldPtYGWYLyJnm7JxcjetO1bxVvD1xMXCD7VwXCM-6HHA3AXRqPZKb6bzAMDyN_m4au3CvcXmON4UuJ7mM6Gsy302Dt_6F6SeksEYhMlEyIpSxwwk2TGaG5BWS5cWeaKOi0yrSyY0lqmGXfCKGm4capUzHEK0vLcZduoMZ6MYQdhBSJ13I9cagY0VyKlwJIyDQotjEITHX3AU0wr5YviU-M4gll4MIsIZpE0UScg-HllUK2OJ7wti9qWxV-2bKLjD_yL-lWa_TLn7n_MuYdW0-gUgTa2jxrzl1c48HXG3LTQSrtz1um10HI3ZWEU3VZ0s3fK0s73
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD7UCtoX8Ypbb_OgTxqYJHPJCD60q3XXdlfBLRRfxrmclJZlU5oV6f_xh3Zmkl0VRfChL4GEYRLOnDmXnO87A_AcXTD8oqozWVQmY7n1WWWpzKQruSiFp4ZHNvJkKkaH7MMRP9qAHysuTEK7r0qSyVKvyW4seP6Q-hZlx4TO8h5KuY8X30Oi1r4Zvw2r-qIo9t7NhqOsP0sgc7mSeSYpyz0ym5fWGu5QOS58XVeKeiNKoxza2jlmGPfCKmm59apWzHOK0vHKl2Hea3CdhRw9AgeHPafiNP2eCgEq5T0j5--f-pvXS4cD_FF5TQ5t7zbc6iNRstOpzh3YwMVduDHpa-334MvH7P3cTXfcRQeXI5PGR1xRd3OyIONILUEyxPm8fU0-NcsIPAozzn5Susj4F8A6aWryGc_ak_Y-HF6J9B7A5qJZ4EMgCkXhebhyaRjSSomCIsvrIjaGYRQH8HIlKX3WNdzQ69bKSa46yFUnuep8ALtRmOuRsVl2etCcH-t-7-kQxAoM3lpKZxjj0hp0pYzN3YJxsqUbwKvVUuh-B7f_eOf2_w1_BjdHs8mBPhhP9x_BVpG0ImLUHsPm8vwbPglBzdI-TTpF4OtVK_El3TUDuw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxQxFD7UCsUX8YrrNQ_6pKFJJpeJ4EPdunatuxZsofgScxspLDNLZ0X6r_yJJjOzq6IIPvRlYIYwM3w5Sc7J-b4TgKfRp4lflhVWrLSYUxdw6YjCyhdCFjIQK7IaeTaXByf83ak43YLvay1Mx3ZfpyR7TUOu0lSvdpeh2t0I33jyAlIYzIpeFY3pQKs8jBffUtDWvprupx5-xtjkzfH4AA_nCmBPtaJYEU5D5I4Wzlnho_ZChqoqNQlWFlb76CrvueUiSKeVEy7oSvMgSFRelKFI770CV1NkRHO4N5bjza5Oij-YJmJQ5_z9V39bAbuDAv7IwnaL2-QGXB-8UrTXm9FN2Ir1LdiZDXn32_DpA3678PM9f9FT59CsCZlj1N-c1WiaZSYRjeNi0b5ER03GMlk2Ov4p70LTX8jrqKnQx7hsz9o7cHIp6N2F7bqp4z1AOkoWRLoKZXkkpZaMRE4rlovEcBJH8HyNlFn2xTfMpsxyh6tJuJoOV0NH8DqDuWmZC2d3D5rzL2YYhyY5tDKmlVspbzkXytnoC5ULvaWJyhV-BC_WXWGG0dz-45v3_6_5E9g52p-Y99P54QO4xjqjyHS1h7C9Ov8aHyX_ZuUedyaF4PNl2_APbKcIHg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=O-GlcNAcylation+Modification+in+Immune+Cells%3A+Potential+Therapeutic+Implications+of+Sepsis&rft.jtitle=Intensive+care+research&rft.au=Huang%2C+ZhenZhen&rft.au=Qin%2C+YuanMei&rft.date=2023-09-01&rft.issn=2666-9862&rft.eissn=2666-9862&rft.volume=3&rft.issue=3&rft.spage=204&rft.epage=214&rft_id=info:doi/10.1007%2Fs44231-023-00048-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s44231_023_00048_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2666-9862&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2666-9862&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2666-9862&client=summon